Improving the efficacy of late-line immunotherapy for advanced esophageal cancer: the addition of local radiotherapy
Adding RT to second-line or later immunotherapy regimens for EC correlates with enhanced survival outcomes and manageable toxicity.
Authors
- Xiaojuan Zhou (ORCID: https://orcid.org/0000-0001-6382-120X)
- Jin Wang (ORCID: https://orcid.org/0000-0001-9451-6961)
- Bingwen Zou (ORCID: https://orcid.org/0000-0002-0825-3657)
- Ruixuan Yu
- Lin Zhou (ORCID: https://orcid.org/0000-0002-6428-7392)
- Yong Xu (ORCID: https://orcid.org/0000-0001-6787-1618)
- Youling Gong (ORCID: https://orcid.org/0000-0001-8230-5892)
- Yalin He
- Ying‐Zhou Chen (ORCID: https://orcid.org/0009-0005-8068-3001)
- Meijuan Huang (ORCID: https://orcid.org/0000-0002-3390-9697)
- Yongsheng Wang (ORCID: https://orcid.org/0000-0001-7450-0006)
- You Lü (ORCID: https://orcid.org/0000-0003-1671-1408)
- Yongmei Liu (ORCID: https://orcid.org/0000-0002-6342-5407)
- Feng Peng
Institutions
- Sichuan University (CN)
- Sichuan Cancer Hospital (CN)
Publication Details
- Journal
- Therapeutic Advances in Gastroenterology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1177/17562848251371785
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00